Position in AMGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,162,633,435
+$105,101,701 QoQ
Shares Held
3,304,344
+2.3% QoQ
Ownership
0.612%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 85.99843115607818.ToString("F0")%
Shared 6.622101088748629.ToString("F0")%
None 7.37946775517319.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $16,975,027,289 across 14 Drug Manufacturers - General names. AMGN ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,832,514 | $3,870,099,719 | |
| 2 | LLY |
ELI LILLY & Co
|
3,895,925 | $3,583,354,934 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,456,039 | $1,859,206,929 | |
| 4 | ABBV |
AbbVie Inc.
|
7,411,238 | $1,611,870,150 | |
| 5 | NVS |
Novartis AG
|
8,110,116 | $1,238,820,217 | |
| 6 | AMGN |
Amgen Inc
This page
|
3,304,344 | $1,162,633,435 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,762,589 | $1,137,951,021 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,722,929 | $1,076,344,612 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,162,633,435 | 3,304,344 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,057,531,734 | 3,230,979 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $896,998,095 | 3,178,590 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $844,310,376 | 3,023,926 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $941,050,792 | 3,020,545 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $781,327,042 | 2,997,725 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $905,663,033 | 2,810,785 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $844,124,604 | 2,701,631 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $722,004,481 | 2,539,408 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $713,362,749 | 2,476,782 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $648,551,741 | 2,413,126 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $531,172,191 | 2,392,452 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $566,833,398 | 2,344,709 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $625,584,052 | 2,381,907 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $558,587,630 | 2,478,206 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $604,514,613 | 2,484,647 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $595,362,049 | 2,462,005 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $582,909,643 | 2,591,055 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $565,375,106 | 2,658,712 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $649,414,106 | 2,664,263 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $658,759,806 | 2,647,642 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $610,680,395 | 2,656,056 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $669,776,664 | 2,635,256 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $605,660,648 | 2,567,882 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $512,041,040 | 2,525,729 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||